Certified by Founder Lodge
Resalis Therapeutics
Italy - Turin, Piedmont
START UP
1 Disclosed Funding Rounds $10,952,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease.
The company is applying its unique
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 08 ,2024 | Pre Series A | $10,952,000 |
Sunstone Life Science Ventures
Claris Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
